162 related articles for article (PubMed ID: 35878221)
1. Roughness of Production Conditions: Does It Really Affect Stability of IgG-Based Antivenoms?
Mateljak Lukačević S; Kurtović T; Borić J; Halassy B
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878221
[TBL] [Abstract][Full Text] [Related]
2. Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches.
Mateljak Lukačević S; Kurtović T; Lang Balija M; Brgles M; Steinberger S; Marchetti-Deschmann M; Halassy B
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33327454
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
Otero-Patiño R; Segura A; Herrera M; Angulo Y; León G; Gutiérrez JM; Barona J; Estrada S; Pereañez A; Quintana JC; Vargas LJ; Gómez JP; Díaz A; Suárez AM; Fernández J; Ramírez P; Fabra P; Perea M; Fernández D; Arroyo Y; Betancur D; Pupo L; Córdoba EA; Ramírez CE; Arrieta AB; Rivero A; Mosquera DC; Conrado NL; Ortiz R
Toxicon; 2012 Feb; 59(2):344-55. PubMed ID: 22146491
[TBL] [Abstract][Full Text] [Related]
4. A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms.
Otero R; Gutiérrez JM; Rojas G; Núñez V; Díaz A; Miranda E; Uribe AF; Silva JF; Ospina JG; Medina Y; Toro MF; García ME; León G; García M; Lizano S; De La Torre J; Márquez J; Mena Y; González N; Arenas LC; Puzón A; Blanco N; Sierra A; Espinal ME; Lozano R
Toxicon; 1999 Jun; 37(6):895-908. PubMed ID: 10340829
[TBL] [Abstract][Full Text] [Related]
5. Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation.
García M; Monge M; León G; Lizano S; Segura E; Solano G; Rojas G; Gutiérrez JM
Biologicals; 2002 Jun; 30(2):143-51. PubMed ID: 12127316
[TBL] [Abstract][Full Text] [Related]
6. Purification of equine whole IgG snake antivenom by using an aqueous two phase system as a primary purification step.
Vargas M; Segura Á; Villalta M; Herrera M; Gutiérrez JM; León G
Biologicals; 2015 Jan; 43(1):37-46. PubMed ID: 25458474
[TBL] [Abstract][Full Text] [Related]
7. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
8. Refinement strategy for antivenom preparation of high yield and quality.
Kurtović T; Lang Balija M; Brgles M; Sviben D; Tunjić M; Cajner H; Marchetti-Deschmann M; Allmaier G; Halassy B
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007431. PubMed ID: 31206512
[TBL] [Abstract][Full Text] [Related]
9. Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature.
Segura A; Herrera M; González E; Vargas M; Solano G; Gutiérrez JM; León G
Toxicon; 2009 May; 53(6):609-15. PubMed ID: 19673074
[TBL] [Abstract][Full Text] [Related]
10. Critical aspects on traditional antivenom production processes and their optimization by factorial analysis.
Zurbano BN; Tavarone E; Viacava BG; Dokmetjian JC; Cascone O; Fingermann M
Biologicals; 2020 Nov; 68():65-73. PubMed ID: 32912811
[TBL] [Abstract][Full Text] [Related]
11. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols.
León G; Lomonte B; Gutiérrez JM
Toxicon; 2005 Jan; 45(1):123-8. PubMed ID: 15581691
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs.
Herrera M; León G; Segura A; Meneses F; Lomonte B; Chippaux JP; Gutiérrez JM
Toxicon; 2005 Dec; 46(7):775-81. PubMed ID: 16183094
[TBL] [Abstract][Full Text] [Related]
13. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
[TBL] [Abstract][Full Text] [Related]
14. Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography.
Raweerith R; Ratanabanangkoon K
J Immunol Methods; 2003 Nov; 282(1-2):63-72. PubMed ID: 14604541
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the viral safety of antivenoms fractionated from equine plasma.
Burnouf T; Griffiths E; Padilla A; Seddik S; Stephano MA; Gutiérrez JM
Biologicals; 2004 Sep; 32(3):115-28. PubMed ID: 15536042
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows.
Estrada R; Herrera M; Segura A; Araya J; Boschini C; Gutiérrez JM; León G
Biologicals; 2010 Nov; 38(6):664-9. PubMed ID: 20833066
[TBL] [Abstract][Full Text] [Related]
17. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
[TBL] [Abstract][Full Text] [Related]
18. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
[TBL] [Abstract][Full Text] [Related]
19. Selective immunoglobulin aggregates removal in antivenoms by a simple chromatographic step based on a monolithic stationary phase.
Blanch NB; Cascone O; Fingermann M
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123978. PubMed ID: 38142501
[TBL] [Abstract][Full Text] [Related]
20. The application of laboratory-based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation.
Patra A; Herrera M; Gutiérrez JM; Mukherjee AK
Drug Test Anal; 2021 Aug; 13(8):1471-1489. PubMed ID: 34089574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
